Literature DB >> 26885020

Effects of down-regulation of clusterin by small interference RNA on human acute myeloid leukemia cells.

Xiaoli Wang1, Ruidong Liu1, Yanxia Wang2, Hengjuan Cai3, Lei Zhang4.   

Abstract

AIMS AND
BACKGROUND: Up-regulation of clusterin is associated with the survival and progression of various malignancies, and down-regulation of clusterin promotes apoptosis and inhibits invasion. The aim of this study was to explore the effect of clusterin small interference RNA (siRNA) on the proliferation, apoptosis and invasion of HL-60 acute myeloid leukemia (AML) cells.
METHODS: siRNA transfection was performed using Lipofectamine™2000 reagent. Relative protein expressions were quantified by Western blot. Trypan blue assay was performed to assess tumor cell proliferation after siRNA transfection. The cytotoxic effect of clusterin siRNA on leukemic cells was measured using MTT assay. Apoptosis was detected using fluorescence microscopy assay. Migration and invasion was detected after clusterin was silenced.
RESULTS: Clusterin siRNA clearly lowered clusterin protein levels in a time- dependent manner, leading to marked inhibition of cell survival, proliferation and invasion. Furthermore, clusterin down-regulation significantly enhanced the extent of HL-60 apoptotic cells.
CONCLUSIONS: Our results suggest that the down-regulation of clusterin by siRNA can effectively trigger apoptosis and inhibit the proliferation and invasion of leukemic cells. Therefore, clusterin siRNA may be a potent adjuvant in AML therapy.

Entities:  

Keywords:  Acute myeloid leukemia; apoptosis; clusterin; invasion; small interference RNA

Year:  2015        PMID: 26885020      PMCID: PMC4723865     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  27 in total

1.  Expression of the secreted form of clusterin protein in renal cell carcinoma as a predictor of disease extension.

Authors:  Toshifumi Kurahashi; Mototsugu Muramaki; Kazuki Yamanaka; Isao Hara; Hideaki Miyake
Journal:  BJU Int       Date:  2005-10       Impact factor: 5.588

2.  Nuclear clusterin/XIP8, an x-ray-induced Ku70-binding protein that signals cell death.

Authors:  C R Yang; K Leskov; K Hosley-Eberlein; T Criswell; J J Pink; T J Kinsella; D A Boothman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 3.  Clusterin: the intriguing guises of a widely expressed glycoprotein.

Authors:  D E Jenne; J Tschopp
Journal:  Trends Biochem Sci       Date:  1992-04       Impact factor: 13.807

Review 4.  The prevalent predicament of relapsed acute myeloid leukemia.

Authors:  Jeffrey Szer
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2012

5.  Introducing the clusterin gene into human renal cell carcinoma cells enhances their metastatic potential.

Authors:  Hideaki Miyake; Martin E Gleave; Soichi Arakawa; Sadao Kamidono; Isao Hara
Journal:  J Urol       Date:  2002-05       Impact factor: 7.450

Review 6.  Clusterin: physiologic and pathophysiologic considerations.

Authors:  M E Rosenberg; J Silkensen
Journal:  Int J Biochem Cell Biol       Date:  1995-07       Impact factor: 5.085

Review 7.  The role of cytokines in acute myeloid leukemia: a systematic review.

Authors:  Tomas Kupsa; Jan Milos Horacek; Ladislav Jebavy
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2012-12-07       Impact factor: 1.245

Review 8.  Clusterin/apolipoprotein J in human aging and cancer.

Authors:  Ioannis P Trougakos; Efstathios S Gonos
Journal:  Int J Biochem Cell Biol       Date:  2002-11       Impact factor: 5.085

Review 9.  Clusterin: a role in cell survival in the face of apoptosis?

Authors:  C Koch-Brandt; C Morgans
Journal:  Prog Mol Subcell Biol       Date:  1996

10.  Clusterin overexpression and relapse-free survival in breast cancer.

Authors:  Cha Kyong Yom; Hee-Yeon Woo; Sun Young Min; So Young Kang; Hee Sung Kim
Journal:  Anticancer Res       Date:  2009-10       Impact factor: 2.480

View more
  2 in total

1.  A New Approach for the Diagnosis of Myelodysplastic Syndrome Subtypes Based on Protein Interaction Analysis.

Authors:  Leona Chrastinová; Ondřej Pastva; Markéta Bocková; Nicholas S Lynn; Pavel Šácha; Martin Hubálek; Jiří Suttnar; Roman Kotlín; Jana Štikarová; Alžběta Hlaváčková; Kristýna Pimková; Jaroslav Čermák; Jiří Homola; Jan E Dyr
Journal:  Sci Rep       Date:  2019-09-02       Impact factor: 4.379

2.  Different regulation of PARP1, PARP2, PARP3 and TRPM2 genes expression in acute myeloid leukemia cells.

Authors:  Paulina Gil-Kulik; Ewa Dudzińska; Elżbieta Radzikowska-Büchner; Joanna Wawer; Mariusz Jojczuk; Adam Nogalski; Genowefa Anna Wawer; Marcin Feldo; Wojciech Kocki; Maria Cioch; Anna Bogucka-Kocka; Mansur Rahnama; Janusz Kocki
Journal:  BMC Cancer       Date:  2020-05-18       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.